Global Hepatitis Diagnostics Test Market

The term Hepatitis broadly means inflammation of the liver. Heavy alcohol use, some medications, toxins, and certain medical conditions can cause hepatitis. Also, hepatitis is often caused due to viral infection. Several factors such as increasing awareness for monitoring and screening procedures, increasing prevalence of hepatitis, and growing demand for diagnostic techniques are likely to force the demand for hepatitis diagnostic tests in the global market over the forecast period. For instance, as per the World Health Organization data of 2018, around 257 million people are living with hepatitis B virus infection. However, limited facilities or services for hepatitis testing along with limited access to reliable and low-cost HBV and HCV diagnostics are few factors restraining the growth of the market over the forecast period.
On the basis of the test segment, liver biopsy is anticipated to represent the most profitable share in the global hepatitis diagnostic tests market during the forecast period. The growth of the liver biopsy segment is mainly attributed due to it provides highly accurate results even in small samples compared to traditional tests. Also, the versatile applications and ease of diagnosis have made liver biopsy quite more popular in recent years.

Global Hepatitis Diagnostics Test industry valued approximately USD 4.11 billion in 2018 is anticipated to grow with a healthy growth rate of more than 6.81% over the forecast period 2019-2026 and is estimated to reach USD 6.96 billion by 2026.

The regional analysis of the Hepatitis Diagnostics Test Market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America, and ROW. North America holds the leading position in the critical care diagnostics market owing to the presence of well-developed healthcare infrastructure along with the broad presence of prominent players in the region. Whereas, Asia-Pacific is expected to emerge as the fastest-growing region in terms of market share. The growth of the Asia-Pacific region is witnessed owing to the rising prevalence of hepatitis especially in countries such as India and China, along with the rising commercial availability of advanced products across the region.
The key manufacturers involved in the market are Siemens AG, Abbott Laboratories, MedMira Inc, Qaigen Inc, Diasorin S.p. A, Hologic Inc, Bio-Rad Laboratories Inc, BioMeriuex, Beckman Coulter Inc (Danaher Corporation), and F. Hoffmann Roche.
The detailed segments and sub-segment of the market are explained below:

By Test Type: Blood Test, Imaging Test, Liver Biopsy

Review our report at
To review more reports on Upcoming topics, visit us at

Data drives better decisions
Bizwit Research & Consulting LLP